C Irlé

781 total citations
23 papers, 664 citations indexed

About

C Irlé is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, C Irlé has authored 23 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in C Irlé's work include T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). C Irlé is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). C Irlé collaborates with scholars based in Switzerland, United States and Germany. C Irlé's co-authors include P F Piguet, P Vassalli, G.B. Ryan, Guido Majno, Giulio Gabbiani, W. J. Cliff, A. Termijtelen, Jack Gorski, Bernard Mach and Jack W. Singer and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

C Irlé

23 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Irlé Switzerland 10 378 143 133 123 89 23 664
S Strober United States 17 520 1.4× 249 1.7× 135 1.0× 112 0.9× 137 1.5× 42 809
Ferdinand C. Breedveld Netherlands 11 392 1.0× 83 0.6× 94 0.7× 101 0.8× 235 2.6× 12 879
S. O. Wawryk Australia 5 298 0.8× 70 0.5× 63 0.5× 99 0.8× 127 1.4× 7 599
R Andreesen Germany 10 396 1.0× 63 0.4× 155 1.2× 120 1.0× 64 0.7× 15 676
S Colella Italy 8 231 0.6× 162 1.1× 100 0.8× 199 1.6× 62 0.7× 11 809
Jacques Banchereau France 15 933 2.5× 164 1.1× 171 1.3× 189 1.5× 100 1.1× 19 1.2k
M. C. Jendro Germany 13 352 0.9× 75 0.5× 174 1.3× 114 0.9× 145 1.6× 22 867
J H Phillips United States 9 828 2.2× 186 1.3× 199 1.5× 79 0.6× 66 0.7× 11 959
F. C. Schmalsteig United States 4 317 0.8× 113 0.8× 47 0.4× 129 1.0× 68 0.8× 4 571
Ch. Huber Austria 12 239 0.6× 109 0.8× 128 1.0× 84 0.7× 38 0.4× 38 594

Countries citing papers authored by C Irlé

Since Specialization
Citations

This map shows the geographic impact of C Irlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Irlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Irlé more than expected).

Fields of papers citing papers by C Irlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Irlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Irlé. The network helps show where C Irlé may publish in the future.

Co-authorship network of co-authors of C Irlé

This figure shows the co-authorship network connecting the top 25 collaborators of C Irlé. A scholar is included among the top collaborators of C Irlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Irlé. C Irlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irlé, C & Jonathan Weintraub. (2016). Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma. SHILAP Revista de lepidopterología. 2016. 1–3. 7 indexed citations
2.
Gautschi, Oliver, Katharina König, Reinhard Büttner, et al.. (2015). Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy. Oncology Research and Treatment. 38(11). 560–569. 5 indexed citations
3.
Popescu, Răzvan, et al.. (2010). Rapid Anaemia Control with Epoetin: Results of a Swiss Survey on Treatment of Chemotherapy-Induced Anaemia. Acta Haematologica. 123(2). 129–134. 1 indexed citations
4.
Seger, Reinhard, Cornelia Betzler, Norbert Graf, et al.. (1990). Bare lymphocyte syndrome — combined immunodeficiency and neutrophil dysfunction. European Journal of Pediatrics. 149(10). 700–704. 3 indexed citations
5.
Gorski, Jack, C Irlé, E. Mickelson, et al.. (1989). Correlation of structure with T cell responses of the three members of the HLA-DRw52 allelic series.. The Journal of Experimental Medicine. 170(3). 1027–1032. 23 indexed citations
6.
Demotz, Stéphane, et al.. (1989). Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.. The Journal of Immunology. 143(12). 3881–3886. 60 indexed citations
7.
Jeannet, M, C Irlé, F Bauters, et al.. (1989). MHC related genetic susceptibility to Hodgkin's disease.. PubMed. 31(2). 149–52. 5 indexed citations
8.
Irlé, C, J.‐M. Tiercy, S Fuggle, et al.. (1988). Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.. The Journal of Experimental Medicine. 167(3). 853–872. 23 indexed citations
9.
Storb, Rainer, H. Joachim Deeg, L Fisher, et al.. (1988). Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood. 71(2). 293–298. 6 indexed citations
10.
Leski, M, et al.. (1988). EFFECT OF FACTORS INHIBITING HLA-DR ANTIBODIES BEFORE TRANSPLANTATION ON KIDNEY GRAFT SURVIVAL. Transplantation. 46(4). 581–584. 5 indexed citations
11.
Storb, Rainer, H. Joachim Deeg, Lloyd D. Fisher, et al.. (1988). Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood. 71(2). 293–298. 111 indexed citations
12.
Chapuis, B, Claudine Helg, P Maurice, et al.. (1988). [Super intensive treatment followed by bone marrow autograft in cases of hematologic neoplasms and solid tumors].. PubMed. 118(10). 341–6. 1 indexed citations
13.
Gorski, Jack, A. Termijtelen, J.-M. Dayer, et al.. (1988). Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types. The Journal of Immunology. 140(1). 336–337. 48 indexed citations
14.
Irlé, C, B Chapuis, M Jeannet, et al.. (1987). Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.. PubMed. 19(1 Pt 3). 2674–7. 7 indexed citations
15.
Aapro, Matti, et al.. (1987). [Quantitative detection and elimination of neuroblastoma cells in vitro. Comparative study of the efficacy of an immunomagnetic method and lymphokine-activated killer cells].. PubMed. 117(46). 1832–4. 1 indexed citations
16.
Irlé, C, Mirjam Kaestli, Matti Aapro, B Chapuis, & M Jeannet. (1987). Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1.. PubMed. 15(2). 163–70. 2 indexed citations
17.
Chapuis, B, P Maurice, Claudine Helg, et al.. (1985). [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].. PubMed. 115(43). 1475–2. 1 indexed citations
18.
Cheever, Martin A., Philip D. Greenberg, C Irlé, et al.. (1984). Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.. The Journal of Immunology. 132(5). 2259–2265. 89 indexed citations
19.
Piguet, P F, et al.. (1981). Post-thymic T lymphocyte maturation during ontogenesis.. The Journal of Experimental Medicine. 154(3). 581–593. 68 indexed citations
20.
Irlé, C, P F Piguet, & P Vassalli. (1978). In vitro maturation of immature thymocytes into immunocompetent T cells in the absence of direct thymic influence. The Journal of Experimental Medicine. 148(1). 32–45. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Strober Breakdown of academic impact, for papers by Ferdinand C. Breedveld Breakdown of academic impact, for papers by S. O. Wawryk Breakdown of academic impact, for papers by R Andreesen Breakdown of academic impact, for papers by S Colella Breakdown of academic impact, for papers by Jacques Banchereau Breakdown of academic impact, for papers by M. C. Jendro Breakdown of academic impact, for papers by J H Phillips Breakdown of academic impact, for papers by F. C. Schmalsteig Breakdown of academic impact, for papers by Ch. Huber
Rankless by CCL
2026